Good news! Moderna & Pfizer enter late stage vaccine trial

It’s great to hear that Moderna is entering late-stage vaccine trials for Covid-19. We certainly hope they will be able to provide a vaccine soon. With about 200 vaccines being developed, many undergoing clinical trials, we certainly hope one will emerge as a viable product for the good of mankind.

Apparently, Moderna will be pricing it’s vaccine higher than what it’s peers will offer. Is this the right thing to do at a time like this? Their stock price would already have risen significantly with news of its vaccine. Would their pricing strategy backfire on them?

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s